As of 2024-12-11, the Intrinsic Value of Avanos Medical Inc (AVNS) is
25.52 USD. This AVNS valuation is based on the model Discounted Cash Flows (Growth Exit 5Y).
With the current market price of 18.69 USD, the upside of Avanos Medical Inc is
36.50%.
The range of the Intrinsic Value is 15.51 - 67.42 USD
25.52 USD
Intrinsic Value
AVNS Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
15.51 - 67.42 |
25.52 |
36.5% |
| DCF (Growth 10y) |
21.18 - 84.47 |
33.46 |
79.0% |
| DCF (EBITDA 5y) |
19.93 - 26.72 |
22.56 |
20.7% |
| DCF (EBITDA 10y) |
25.71 - 36.12 |
29.85 |
59.7% |
| Fair Value |
8.54 - 8.54 |
8.54 |
-54.31% |
| P/E |
3.07 - 17.51 |
9.27 |
-50.4% |
| EV/EBITDA |
11.19 - 27.46 |
18.91 |
1.2% |
| EPV |
11.59 - 15.74 |
13.66 |
-26.9% |
| DDM - Stable |
4.11 - 18.18 |
11.14 |
-40.4% |
| DDM - Multi |
11.07 - 37.98 |
17.13 |
-8.3% |
AVNS Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
858.99 |
| Beta |
1.11 |
| Outstanding shares (mil) |
45.96 |
| Enterprise Value (mil) |
931.99 |
| Market risk premium |
4.60% |
| Cost of Equity |
7.75% |
| Cost of Debt |
6.13% |
| WACC |
7.23% |